|
Volumn 294, Issue 5548, 2001, Pages 1834-
|
Research on resistance to cancer drug gleevec [5]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCR ABL PROTEIN;
IMATINIB;
PROTEIN KINASE INHIBITOR;
ADVANCED CANCER;
CANCER RESISTANCE;
CHRONIC MYELOID LEUKEMIA;
GENE MUTATION;
LETTER;
PHILADELPHIA 1 CHROMOSOME;
PRIORITY JOURNAL;
RESEARCH;
ANTINEOPLASTIC AGENTS;
DRUG RESISTANCE, NEOPLASM;
FUSION PROTEINS, BCR-ABL;
GENE AMPLIFICATION;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
LEUKEMIA, MYELOID, CHRONIC;
PIPERAZINES;
POINT MUTATION;
PROTEIN KINASES;
PROTEIN STRUCTURE, TERTIARY;
PYRIMIDINES;
REPRODUCIBILITY OF RESULTS;
|
EID: 0035976571
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (40)
|
References (8)
|